Aigen Investment Management LP purchased a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional ...

As the FTC continues to crack down on pharmaceutical manufacturers’ allegedly improper listing of patents in the FDA Orange ...

Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) had its price target increased by Piper Sandler from $9.00 to $11.00 in a ...

Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals Inc. are among a group of generic-drug manufacturers that will face some ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

Have you been paying attention to shares of Amneal Pharmaceuticals (AMRX)? Shares have been on the move with the stock up 6.2% over the past month. The stock hit a new 52-week high of $9.32 in the ...

On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $9.2 which represents a slight increase of $0.47 or 5.38% from the prior close of $8.73. The stock opened at ...

Amneal Pharmaceuticals Inc (AMRX) reports robust Q3 performance with significant strides in new markets and innovative product launches.

Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Amneal Pharma ( (AMRX)) has released its Q3 earnings. Here is a breakdown of the information Amneal Pharma presented to its investors. Amneal Pharmaceuticals, Inc. is a global pharmaceutical company ...

While the top- and bottom-line numbers for Amneal (AMRX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics ...

Amneal Pharmaceuticals Q3 sales rose 13% to $702.47 million, beating estimates. EPS hit $0.16, above consensus, driven by ...